WallStreetZenWallStreetZen

NASDAQ: FHTX
Foghorn Therapeutics Inc Stock

$7.20-0.34 (-4.51%)
Updated Feb 27, 2024
FHTX Price
$7.20
Fair Value Price
$3.01
Market Cap
$303.96M
52 Week Low
$2.70
52 Week High
$9.97
P/E
-2.93x
P/B
-5.3x
P/S
6.45x
PEG
N/A
Dividend Yield
N/A
Revenue
$32.57M
Earnings
-$103.21M
Gross Margin
100%
Operating Margin
-310%
Profit Margin
-316.9%
Debt to Equity
-6.46
Operating Cash Flow
-$119M
Beta
1.35
Next Earnings
Mar 9, 2024
Ex-Dividend
N/A
Next Dividend
N/A

FHTX Overview

Foghorn Therapeutics Inc. is a clinical-stage biopharmaceutical company developing medicines targeting genetically determined dependencies within the chromatin regulatory system using its Gene Traffic Control platform. Foghorn Therapeutics has a research collaborationsand license agreements with Merck and Loxo Oncology.the company was incorporated in 2015 and is headquartered in Cambridge, MA.

Zen Score

Industry Average (22)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how FHTX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

FHTX ($7.20) is overvalued by 138.84% relative to our estimate of its Fair Value price of $3.01 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
FHTX ($7.20) is not significantly undervalued (138.84%) relative to our estimate of its Fair Value price of $3.01 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
FHTX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more FHTX due diligence checks available for Premium users.

Be the first to know about important FHTX news, forecast changes, insider trades & much more!

FHTX News

Valuation

FHTX fair value

Fair Value of FHTX stock based on Discounted Cash Flow (DCF)
Price
$7.20
Fair Value
$3.01
Overvalued by
138.84%
FHTX ($7.20) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
FHTX ($7.20) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
FHTX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

FHTX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-2.93x
Industry
14.95x
Market
36.02x

FHTX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-5.3x
Industry
6.23x

FHTX's financial health

Profit margin

Revenue
$17.5M
Net Income
-$14.3M
Profit Margin
-82.1%
FHTX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
FHTX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$313.4M
Liabilities
$370.8M
Debt to equity
-6.46
FHTX's short-term assets ($265.44M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
FHTX's long-term liabilities ($318.80M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
FHTX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
FHTX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$27.2M
Investing
$38.4M
Financing
$1.4M
FHTX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

FHTX vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
FHTX$303.96M-4.51%-2.93x-5.30x
TSVT$301.72M+8.36%-1.58x0.98x
PBYI$307.31M-0.31%92.29x7.93x
TCRX$308.47M-5.01%-2.63x1.83x
AKBA$308.96M+8.61%-4.97x-7.84x

Foghorn Therapeutics Stock FAQ

What is Foghorn Therapeutics's quote symbol?

(NASDAQ: FHTX) Foghorn Therapeutics trades on the NASDAQ under the ticker symbol FHTX. Foghorn Therapeutics stock quotes can also be displayed as NASDAQ: FHTX.

If you're new to stock investing, here's how to buy Foghorn Therapeutics stock.

What is the 52 week high and low for Foghorn Therapeutics (NASDAQ: FHTX)?

(NASDAQ: FHTX) Foghorn Therapeutics's 52-week high was $9.97, and its 52-week low was $2.70. It is currently -27.78% from its 52-week high and 166.67% from its 52-week low.

How much is Foghorn Therapeutics stock worth today?

(NASDAQ: FHTX) Foghorn Therapeutics currently has 42,217,126 outstanding shares. With Foghorn Therapeutics stock trading at $7.20 per share, the total value of Foghorn Therapeutics stock (market capitalization) is $303.96M.

Foghorn Therapeutics stock was originally listed at a price of $17.20 in Oct 26, 2020. If you had invested in Foghorn Therapeutics stock at $17.20, your return over the last 3 years would have been -58.14%, for an annualized return of -25.19% (not including any dividends or dividend reinvestments).

How much is Foghorn Therapeutics's stock price per share?

(NASDAQ: FHTX) Foghorn Therapeutics stock price per share is $7.20 today (as of Feb 27, 2024).

What is Foghorn Therapeutics's Market Cap?

(NASDAQ: FHTX) Foghorn Therapeutics's market cap is $303.96M, as of Feb 29, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Foghorn Therapeutics's market cap is calculated by multiplying FHTX's current stock price of $7.20 by FHTX's total outstanding shares of 42,217,126.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.